Suchergebnisse - "Bazzani, Chiara"

PubPharm (58)

1

Effectiveness and safety of filgotinib in rheumatoid arthritis patients : data from the GISEA registry

enthalten in: Clinical and experimental rheumatology | 2024

von Fornaro, M. | Caporali, R. | Biggioggero, M. | +20

2

Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients : data from GISEA registry

enthalten in: Frontiers in medicine | 2024

von Manfredi, A. | Fornaro, M. | Bazzani, C. | +18

3

Comorbidities in the Spondyloarthritis GISEA Cohort : an average treatment effect analysis on patients treated with bDMARDs

enthalten in: Clinical and experimental rheumatology | 2024

von Scagnellato, L. | Collesei, A. | Doria, A. | +46

4

Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders : humoral and cellular immune response

enthalten in: BMC medicine | 2023

von Filippini, F. | Giacomelli, M. | Bazzani, C. | +7

5

Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response

enthalten in: BMC medicine | 2023

von Filippini, F. | Giacomelli, M. | Bazzani, C. | +7

6

Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response

enthalten in: BMC medicine | 2023

von Filippini, F. | Giacomelli, M. | Bazzani, C. | +7

7

CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept

enthalten in: Clinical and experimental rheumatology | 2022

von Masneri, S. | Piantoni, S. | Galoppini, G. | +5

8

Increased COVID-19 mortality in patients with rheumatic diseases : results from the CONTROL-19 study by the Italian Society for Rheumatology

enthalten in: Clinical and experimental rheumatology | 2022

von Zanetti, A. | Carrara, G. | Landolfi, G. | +118

9

Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis

enthalten in: Frontiers in pharmacology | 2022

von Gerardi, M. | Crisafulli, F. | García-Fernandez, A. | +16

10

Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab : results from the Italian GISEA registry

enthalten in: Clinical rheumatology | 2021

von Sebastiani, M. | Venerito, V. | Bugatti, S. | +27

1
2
3
4
5
6
Nächster »
[6]